Inizio Unveils AI-Enabled Advisory Platform Inizio Ignite to Accelerate Pharma Performance
Inizio, a leading global commercialization partner for pharmaceutical and life sciences, unveiled Inizio Ignite, a reimagined and fully integrated advisory partner designed to accelerate pharmaceutical performance through strategy, insights, and innovation.
Digitalization | 09/01/2026 | By Darshana | 369
Variant Bio Launches World's First Agentic AI Genomic Drug Discovery Platform
The agentic AI platform by Variant Bio, named Inference, brings together genetic and multi-omic data with autonomous analysis capabilities, and is already powering pharmaceutical partnerships totaling over USD 200 million.
Digitalization | 09/01/2026 | By News Bureau | 379
Sectra Enters Japan's Digital Pathology Market with Kameda Medical Centre Project
Sectra brings AI-enabled digital pathology workflows to Kameda Medical Centre in partnership with Matsunami Glass.
Digitalization | 07/01/2026 | By News Bureau | 402
Insilico Medicine and Servier Forge AI-Driven Oncology Drug Discovery Alliance
Insilico Medicine, a global leader in artificial intelligence–driven drug discovery, has entered into a multi-year research and development collaboration with Servier, an independent international pharmaceutical company governed by a foundation.
Digitalization | 06/01/2026 | By Darshana | 117
Revvity Launches AI Platform for Molecular and Materials Discovery
Revvity has launched a new AI-powered Models-as-a-Service (MaaS) platform designed to integrate in-silico molecular and materials design with experimental data, enabling continuous learning, improved predictive accuracy, and faster scientific discovery.
Digitalization | 17/12/2025 | By News Bureau | 196
Merck Launches ChemiSphere App to Streamline Digital Data Access and Enhance Lab Efficiency
Merck has launched the ChemiSphere app to streamline digital data access and improve lab efficiency by linking physical products with secure digital workflows, enabling quick access to key documentation such as SDS and CoA.
Digitalization | 17/12/2025 | By News Bureau | 260
Xcell Biosciences and Culture Biosciences Partner to Improve Cell Therapy Quality with AI and ML
Xcell Biosciences has partnered with Culture Biosciences to integrate AI- and ML-driven analytics into cell therapy development. The collaboration leverages a cloud-based platform capable of multivariate analysis, enabling real-time optimisation to enhance cell therapy performance and improve patient outcomes.
Digitalization | 10/12/2025 | By Akanki | 232
FDA Qualifies PathAI's AIM-MASH as First AI Tool for MASH Clinical Trials
PathAI has achieved a regulatory milestone with the FDA qualifying its AIM-MASH AI Assist as the first AI-powered tool for MASH clinical trials. The qualification follows the EMA CHMP’s endorsement earlier this year, reinforcing PathAI’s leadership in advancing AI-driven histopathology solutions across American and European drug-development framework.
Digitalization | 10/12/2025 | By Akanki | 1139
SmartWinnr Launches Medical Simulation to Advance AI Readiness in Pharma and Medtech
SmartWinnr has introduced a new medical simulation platform designed to help pharma and medtech companies accelerate AI readiness. Developed in collaboration with life sciences leaders and AI experts, the solution delivers clinically accurate, compliant, and emotionally intelligent training simulations for healthcare professionals.
Digitalization | 03/12/2025 | By Akanki | 275
Verida: Philips unveils first AI-driven detector-based spectral CT
The new platform integrates AI across the entire imaging chain—from acquisition to reconstruction—to reduce system noise, enhance image clarity, and significantly accelerate clinical workflows.
Digitalization | 02/12/2025 | By Darshana | 346
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy